KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2026)

Twist Bioscience has reported Other Accumulated Expenses over the past 9 years, most recently at $67.8 million for Q1 2026.

  • Quarterly Other Accumulated Expenses rose 841.68% to $67.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $67.8 million through Mar 2026, up 841.68% year-over-year, with the annual reading at $35.2 million for FY2025, 505.16% up from the prior year.
  • Other Accumulated Expenses was $67.8 million for Q1 2026 at Twist Bioscience, up from $13.5 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $67.8 million in Q1 2026 and troughed at $5.2 million in Q4 2024.
  • The 5-year median for Other Accumulated Expenses is $10.0 million (2023), against an average of $15.5 million.
  • Year-over-year, Other Accumulated Expenses tumbled 60.47% in 2023 and then surged 841.68% in 2026.
  • A 5-year view of Other Accumulated Expenses shows it stood at $15.8 million in 2022, then crashed by 59.44% to $6.4 million in 2023, then fell by 18.32% to $5.2 million in 2024, then soared by 156.89% to $13.5 million in 2025, then soared by 403.85% to $67.8 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Other Accumulated Expenses are $67.8 million (Q1 2026), $13.5 million (Q4 2025), and $35.2 million (Q3 2025).